The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease
Open accessAbstract
Paget disease is the most exaggerated example of abnormal bone remodeling, with the primary cellular abnormality in the osteoclast. Mutations in the p62 (sequestosome 1) gene occur in one-third of patients with familial Paget disease and in a minority of patients with sporadic Paget disease, with the P392L amino acid substitution being the most commonly observed mutation. However, it is unknown how p62(P392L) mutation contributes to the development of this disease. To determine the effects of p62(P392L) expression on osteoclasts in vitro and in vivo, we introduced either the p62(P392L) or WT p62 gene into normal osteoclast precursors and targeted p62(P392L) expression to the osteoclast lineage in transgenic mice. p62(P392L)-transduced osteoclast precursors were hyperresponsive to receptor activator of NF-kappaB ligand (RANKL) and TNF-alpha and showed increased NF-kappaB signaling but did not demonstrate increased 1,25-(OH)(2)D(3) responsivity, TAF(II)-17 expression, or nuclear number per osteoclast. Mice expressing p62(P392L) developed increased osteoclast numbers and progressive bone loss, but osteoblast numbers were not coordinately increased, as is seen in Paget disease. These results indicate that p62(P392L) expression on osteoclasts is not sufficient to induce the full pagetic phenotype but suggest that p62 mutations cause a predisposition to the development of Paget disease by increasing the sensitivity of osteoclast precursors to osteoclastogenic cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, overexpression of SQSTM1 variants carrying disease-associated mutations in the UBA domain exhibit a PDB-like skeletal disorder [138,139] as well as impaired spatial learning and long-term memory [140].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 1×
“Both genetic and environmental factors have been proposed as contributing to the etiology of PD, and multiple families with an autosomal dominant mode of inheritance have been described (7, 8).”
BackgroundThe atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway
Sanz, L., Diaz‐Meco, M. T., Nakano, H., & Moscat, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 448
The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation
Sanz, L., Sánchez‐Gómez, P., Lallena, M., Díaz-Meco, M. T., & Moscat, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350
Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316
Kurihara, N., Chenu, C., MILLER, M., Civin, C. I., & Roodman, G. D. (1990) · Endocrinology · doi:10.1210/endo-126-5-2733 · Cited by 227
Self-citationLiu, B., Yu, S., & Li, T. (2003) · Journal of Oral Pathology and Medicine · doi:10.1034/j.1600-0714.2003.00126.x · Cited by 214
Siris, E. S. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1061 · Cited by 168
Manipulating the mouse embryo a laboratory manual
Nagy, A. (2003) · Cited by 143
Flagged first, then by citations
Research works printed but not linked: 1
- 2000, J. Bone Miner. Res., 15, 2293
Cited by
Sorted by citations
Items 101–128 of 128
Molecular Genetics of Paget's Disease of Bone
Gennari, L., Gianfrancesco, F., Rendina, D., & Merlotti, D. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0024396 · Cited by 2
Michou, L., & Brown, J. P. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2564667 · Cited by 1
Singer, F. R., & Roodman, G. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00081-1 · Cited by 1
Self-citationSinger, F. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00072-x · Cited by 1
Self-citationPaget’s Disease of Bone: Pathogenesis and Treatment
Singer, F. R., & Roodman, G. D. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_12 · Cited by 1
Self-citationDiagnosis and treatment of Paget´s disease of bone: update 2020
Zikán, V. (2020) · Clinical Osteology · doi:10.36290/clo.2020.024 · Cited by 1
SQSTM1 mutations and Paget's disease of bone
Najat, D. (2010) · Nottingham ePrints (University of Nottingham)
Liu, X. (2012) · UKnowledge (University of Kentucky)
Étude épidémiogénétique de familles françaises avec maladie osseuse de Paget
Michou, L., Collet, C., Morissette, J., Audran, M., Thomas, T., Gagnon, É., Launay, J., Laplanche, J., Brown, J. P., & Orcel, P. (2011) · Revue du Rhumatisme · doi:10.1016/j.rhum.2011.07.007
Génétique des maladies osseuses
Michou, L., & Brown, J. P. (2010) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2010.04.022
Paget Disease of Bone in Cyprus: Prevalence, Clinical Characteristics and Physicians' Awareness
Samoutis, G., & Samoutis, A. (2015)
Developmental Aspects of Pagetic Osteoclasts
Galson, D. L., Sun, Q., & Roodman, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805083-5.00004-x
Self-citationViral Etiology of Paget’s Disease of Bone
Reddy, S. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805083-5.00002-6
Self-citationThe role of autophagy in clearance of protein aggregates
Isakson, P. (2011) · NORA - Norwegian Open Research Archives
Kurihara, N., & Roodman, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00085-7
Self-citationA quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone
Michalski, M. N., & Williams, B. O. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.h118.003689
RANKL Signaling Pathway: A Potential Target for Antiresorptive Therapy in Rheumatoid Arthritis
Anjum, S., Bhatti, A., Qadir, F., Ashraf, U., & John, P. C. L. (2021) · NUST Journal of Natural Sciences · doi:10.53992/njns.v3i1.20
Diagnosis | Osteitis deformans or Paget's disease of bone
(2008) · Lab Animal · doi:10.1038/laban1008-450
Incorrect Positioning in Novel POLG Splice Site Mutation and Optic Atrophy
(2011) · Archives of Neurology · doi:10.1001/archneurol.2011.252
Role of TAF12 in the Increased VDR Activity in Paget's Disease of Bone
Kurihara, N. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada613487
Self-citationHorwitz, M. J., & Roodman, G. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6109-0.00077-0
Self-citationReid, I. R., & Seton, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_42
Kurihara, N., & Roodman, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00032-x
Self-citationCruz, M. A. E., Sebinelli, H. G., Ciancaglini, P., Bottini, M., & Ramos, A. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99158-2.00008-5
Paget’s Disease of Bone: Evaluation and Advances in Management
Merlotti, D., & Gennari, L. (2023) · Endocrinology · doi:10.1007/978-3-030-19632-5_11-1
de Calbiac, H. (2019) · theses.fr (ABES) · doi:10.70675/bafe951fz8332z4b0azb55bzac8a4af1955b
Metadata
- Authors
- Kurihara, N., Hiruma, Y., Zhou, H., Subler, M. A., Dempster, D. W., Singer, F. R., Reddy, S. V., Gruber, H. E., Windle, J. J., & Roodman, G. D.
- Affiliations
- VA Pittsburgh Healthcare System (US)
- University of Pittsburgh (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Medical University of South Carolina (US)
- Carolinas Medical Center (US)
- Corresponding author
- Kurihara, Noriyoshi
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-01-02
- Volume
- 117
- Issue
- 1
- Pages
- 133-142
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1705822
- OpenAlex
- W2116217447
- Cited by
- 127
- References
- 25
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 7
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- National Institutes of Health (UL1TR000005, CA16059)
- VA Pittsburgh Healthcare System
- National Cancer Institute (P30CA16059, P30CA016059)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR049363)
- National Center for Advancing Translational Sciences
- Medical Research and Materiel Command
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- p62, Paget disease, osteoclastogenesis, osteoclasts, bone remodeling, RANKL, NF-κB signaling, TNF-α, 1,25-dihydroxyvitamin D3, transgenic mice, bone loss, osteoclast precursors
- MeSH terms
- Sequestosome-1 Protein, Calcitriol, Cell Division, Humans, Mutation, Osteitis Deformans, Osteoclasts, Proteins, Tumor Necrosis Factor-alpha, Gene Transfer Techniques, Genetic Predisposition to Disease, Adaptor Proteins, Signal Transducing, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
